Contact Us
Environment
News
Careers
Home
About Us
Our Products
Manufacturing
Sales
NHS
Amgen's BiTE® antibody blinatumomab (AMG 103) achieved high rate of complete response
|
Merck total revenues increase 3.2% to € 2.6 billion
|
Pfizer provides topline results from Phase 3 study of Torisel®
|
In drug-approval race, US FDA ahead of Canada, Europe
|
GlaxoSmithKline to fully acquire Cellzome for £61 million
|
Bristol-Myers Squibb Foundation Announces $15 Million Expansion of Together on Diabetes® to China and India
|
Bristol-Myers Squibb and Tsinghua University Enter Strategic Partnership
|
Blood pressure drugs don't protect against colorectal cancer
|
Statistically significant clinical phase III results of Lu AA21004
|
Vitamin K2: New hope for Parkinson's patients?
|
Our
Services
Our Services
